Guidelines without borders: the case for JAK inhibitors as the first-line immunomodulator COVID-19 treatment.
作者信息
Sweeney Daniel A, Kalil Andre C
机构信息
Division of Pulmonary, Critical Care and Sleep Medicine, University of California, San Diego, CA, USA.
Division of Infectious Diseases, Department of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
出版信息
Lancet Respir Med. 2025 Jun;13(6):478-480. doi: 10.1016/S2213-2600(25)00081-5. Epub 2025 May 13.
Abstract
摘要
Zotero 插件